Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Corbus Pharmaceuticals
(CRBP)
NASDAQ
:CRBP
CRBP
Corbus Pharmaceuticals
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Corbus Pharmaceuticals (CRBP) Stock News & Sentiment
Compare
Follow
2,508
Followers
Premium
Company Announcements
Corbus Pharmaceuticals Announces Retirement of Board Member Holmer
3d ago
8K
CRBP
Premium
Ratings
Promising Initial Results and Strong Safety Profile Bolster Buy Rating for Corbus Pharmaceuticals’ CRB-913
10d ago
CRBP
Premium
Ratings
Optimistic Buy Rating for Corbus Pharmaceuticals: Promising Phase 1 Results for CRB-913 in Obesity Treatment
10d ago
CRBP
Premium
Ratings
Buy Rating for Corbus Pharmaceuticals Driven by Promising CRB-913 Developments and Market Potential
10d ago
CRBP
Premium
Company Announcements
Corbus Pharmaceuticals Advances Obesity Treatment with CRB-913
10d ago
8K
CRBP
Premium
Ratings
Corbus Pharmaceuticals: Promising Pipeline and Strategic Plans Justify Buy Rating
1M ago
CRBP
Premium
Company Announcements
Corbus Pharmaceuticals Advances Oncology and Obesity Pipeline
1M ago
CRBP
More CRBP News >
CRBP News on the Web
All News
Bearish News
Bullish News
2025-12-19
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers
rttnews
Neutral
2025-12-16
Why Corbus Pharmaceuticals Holdings, Inc.’s (CRBP) Stock Is Down 5.70%
AAII
Neutral
2025-12-11
Stocks making the biggest moves midday: Oracle, Vail Resorts, GE Vernova, Brinks, Ciena & more
CNBC
Neutral
2025-12-11
RBC Capital says Corbus undervalued as '913 shows hints of weight loss
The Fly
Neutral
2025-12-11
Corbus Reports Positive Phase 1a Results Of CRB-913 In Obesity, Stock Surges - Update
rttnews
Bullish
2025-12-11
Stocks making the biggest moves premarket: Oracle, Oxford Industries, Adobe, Gemini Space Station & more
CNBC
Neutral
2025-12-11
Corbus Prepares to Release Phase 1a Results for CRB-913—A Next-Gen Obesity Drug with Significantly Lower Brain Penetration
Market Chameleon
Neutral
2025-12-11
Corbus Pharma To Report Phase 1a Results Of CRB-913 In Obesity Today
rttnews
Neutral
117
Results | Showing
1
out of
15
News Score - Last 7 Days
Neutral
CRBP
Sector Average
Media Buzz
This Week
2 articles
Weekly Average
3 articles
News Sentiment
This Week
50%
Sector Average
56%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is CRBP’s Media Buzz Sentiment?
2 articles about CRBP were published this week. In an average week, 3 articles are published.
What is CRBP’s weekly average amount of articles?
In an average week, 3 articles about CRBP are published.
What is CRBP’s News Sentiment?
50% of articles about CRBP were positive this week, compared to its sector average of 56%.
Healthcare Stocks that are Trending in the News
CYTK
Cytokinetics
TXG
10x Genomics
ANIP
ANI Pharmaceuticals
HIK
Hikma Pharmaceuticals
PCSA
Processa Pharmaceuticals
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.